logo
Share SHARE
FONT-SIZE Plus   Neg

Earnings Watch For Feb 7 (CTSH, ATVI, HAS, LNKD, RVBD)

Cognizant Technology Solutions Corp. (CTSH), the provider of IT, consulting, and business process outsourcing services, is expected to report fourth quarter results before the markets open. The earnings of the company are expected to increase to $0.91 per share from $0.78 per share reported a year earlier, while quarterly revenues are anticipated to rise to $1.95 billion from last year's $1.66 billion. The shares closed Wednesday at $76.27. (52-wk H/L $79.54/$53.92)

Activision Blizzard, Inc. (ATVI) is scheduled to report fourth quarter results. The world's largest video game publisher is expected to post earnings of $0.72 per share, higher than the year-ago quarter's $0.62 per share. Also, the company is anticipated to generate revenues of $2.44 billion, up from $2.41 billion in the prior-year quarter. The company's shares closed Wednesday's session at $11.94. (52-wk H/L $13.01/$10.45)

Games and toys manufacturer Hasbro Inc. (HAS) is slated to report results for the fourth quarter. The company is expected to report a profit of $1.19 per share, up from $1.06 per share last year, whereas revenues are projected to decline to $1.28 billion from $1.33 billion reported in the prior year quarter. The stock closed Wednesday at $38.17. (52-wk H/L $39.98/$32.00)

Mountain View, California-based LinkedIn Corp. (LNKD) is due to report its fourth quarter results after the close of trading. The professional networking giant is expected to report a profit of $0.19 per share versus $0.12 per share last year, with revenues estimated at $279.50 million. The stock closed Wednesday at $125.77. (52-wk H/L $127.45/$74.32)

Networking solutions company Riverbed Technology, Inc. (RVBD) will report its fourth quarter results today. The San Francisco, California-based company is expected to report earnings of $0.29 per share on revenues of $234.77 million. A year earlier, earnings and revenue were $0.25 per share and $204.02 million respectively. The stock closed Wednesday's regular trading at $20.31. (52-wk H/L $29.59/$13.30)

Biogen Idec Inc. (BIIB), Bunge Limited (BG), Cigna Corp. (CI), FLIR Systems, Inc. (FLIR), Healthways Inc. (HWAY), Kohlberg Kravis Roberts & Co. (KKR), MGIC Investment Corp. (MTG), The New York Times Company (NYT), Post Holdings, Inc. (POST), Sigma-Aldrich Corporation (SIAL), Philip Morris International, Inc. (PM), Columbia Sportswear Company (COLM), Microchip Technology Inc. (MCHP), NCR Corp. (NCR), Republic Services, Inc. (RSG), SunPower Corporation (SPWR) and XL Group plc (XL) are also due to report their results.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Best Buy announced Wednesday its plans to introduce Amazon Alexa and Google Home experiences to its 700 locations across the U.S. starting next month as part of its strategy of pushing smart home technology. A nationwide rollout will be complete by the end of the year. The electronics retailer will expand space at selected stores to better showcase how Amazon's Echo and Google Home interact.. So far this year, 23 novel drugs have already received FDA approval. Now let's take a look at the biotech stocks waiting to hear from the FDA in July. President Donald Trump has continued his assault on one of his favorite targets on Wednesday, lashing out at major media outlets in a series of posts on Twitter. Trump singled out the New York Times and the Washington Post in his tweets, describing the newspapers as "fake news."
comments powered by Disqus
Follow RTT